My Cart [ 0 ]
New Products
New Services
News
Promotions
Home > Search Results
    14 products and services containing "cd79b"
    Please click cd79b to try advanced search.
  • PA007454.m2a: In vivo Grade Recombinant Anti-mouse CD79b Monoclonal Antibody, Mouse IgG2a Kappa (Clone: HM79-16 or HM79b)

    The in vivo grade recombinant anti-mouse CD79b Mouse IgG2a monoclonal antibody was produced in mammalian cells. 
    Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: HM79-16 or HM79b) specifically binds to mouse CD79b.
    Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse CD79b protein.

     

    PA007454.hs: In vivo Grade Recombinant Anti-mouse CD79b Monoclonal Antibody, Armenian hamster IgG Lambda (Clone: HM79-16 or HM79b)

    The in vivo grade recombinant anti-mouse CD79b Armenian hamster IgG monoclonal antibody was produced in mammalian cells. 
    Specificity/Sensitivity: The in vivo grade recombinant hamster monoclonal antibody (clone: HM79-16 or HM79b) specifically binds to mouse CD79b.
    Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse CD79b protein.

  • PA007496.m2a: Recombinant Anti-mouse CD79b Monoclonal Antibody (Clone: HM79-16 or HM79b), Mouse IgG2a Kappa

    Recombinant Mouse IgG2a Monoclonal Antibody.
    Conjugation: Non-conjugated.
    Specificity/Sensitivity: The recombinant HM79-16 or HM79b antibody specifically binds to mouse CD79b protein.
    Applications: Flow cytometry (FC), and Immunohistochemistry - Frozen (IHC-F).

     

    PA007496.h1Fs: Recombinant Anti-mouse CD79b Monoclonal Antibody (Clone: HM79-16 or HM79b), Human IgG1 Fc Silent Kappa

    Recombinant human IgG1 Monoclonal Antibody with Fc silent mutation.
    Conjugation: Non-conjugated.
    Specificity/Sensitivity: The recombinant HM79-16 or HM79b antibody specifically binds to mouse CD79b protein.
    Applications: Flow cytometry (FC), and Immunohistochemistry - Frozen (IHC-F).

     

  • BP005477: Biotinylated Human CD79B Protein with the C-His-Avi Tag

    Source: The recombinant Biotinylated Human CD79B Protein, (amino acids Ala29-Asp159) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Anti-CD79B Antibody protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Biotinylated Human CD79B protein with the C-His tag with the EC50 of 11.5 ng/ml determined by ELISA.
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP001696-CA29: Recombinant Human CD79B Protein

    Source: HEK 293-derived.
    Purity: > 95% by reducing SDS-PAGE.
    Endotoxin: < 0.1 ng/ug (1 IEU/ug).

  • C002P: Cetuximab Biosimilar, Human EGFR Monoclonal Antibody

    Recombinant Chimeric IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The monoclonal antibody cetuximab biosimilar specifically binds to the human EGFR.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by cetuximab.

  • C049P: Gemtuzumab Biosimilar, CD33 Monoclonal Antibody

    Recombinant Humanized IgG4 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade gemtuzumab biosimilar specifically binds to the human CD33 protein.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by gemtuzumab.

  • BP005031: Human CD79B Protein with the C-hFc Tag

    Source: The recombinant Human CD79B Protein, (amino acids Ala29-Asp159) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Human CD79B protein with the C-hFc tag at 0.5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Biotinylated Anti-CD79B Antibody protein with the C-hFc tag with the EC50 of 10.5 ng/ml determined by ELISA.
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

    BP005416: Human CD79B Protein with the C-His-Avi Tag

    Source: The recombinant Human CD79B Protein, (amino acids Ala29-Asp159) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Human CD79B protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/Well). Dose response curve for the recombinant Anti-CD79B Antibody protein with the C-hFc tag with the EC50 of 3.7 ng/ml determined by ELISA.
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • C059P: Mirvetuximab Biosimilar, Human FOLR1 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The monoclonal antibody mirvetuximab biosimilar specifically binds to the human FOLR1 protein.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by mirvetuximab.

  • BP004951: Mouse CD79B Protein with the C-His Tag

    Source: The recombinant Mouse CD79B Protein, (amino acids Val26-Asp158) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
    Activity:
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • C052P: Polatuzumab Biosimilar, CD79B Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The research grade polatuzumab biosimilar specifically binds to the CD79B protein.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by polatuzumab.

See our Privacy Policy